HTLV-III: should testing ever be routine?

Abstract

The authors--who are researchers, physicians, and psychologists at a London teaching hospital--reject routine, indiscriminate screening for HTLV-III antibodies as of limited use in the diagnosis of acquired immunodeficiency syndrome (AIDS); as an ineffective public health measure; and as psychologically, socially, and economically damaging to persons with positive results. They are in favor of testing donated blood and of screening (accompanied by informed consent and counseling) for transplant and semen donors, renal dialysis patients, women in high risk groups contemplating pregnancy or in early pregnancy, and those persons requesting testing. The development of a vaccine or effective anti-HTLV-III treatment would shift the balance to the benefit of other individuals. The authors conclude by urging an immediate campaign of public education to promote safe sexual practices and other behavioral changes.